Gossamer Bio, Inc. (GOSS) Capital expenditures 2018–2025
Gossamer Bio, Inc. (GOSS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$79,000FY2025 · since FY2018: $3.5M → $79,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $79,000 | — |
| FY2024 | $0 | — |
| FY2023 | $0 | -100.0% |
| FY2022 | $410,000 | -73.5% |
| FY2021 | $1.5M | +2.9% |
| FY2020 | $1.5M | -49.3% |
| FY2019 | $3.0M | -15.0% |
| FY2018 | $3.5M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice